Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Strong Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Hot Stock Rockets in ShareProphets
- Buy Barclays (BARC) by Harvey Jones in The Motley Fool
- Avoid Calnex Solutions (CLX) by Steve Moore in ShareProphets
- Avoid CML Microsystems (CML) by Steve Moore in ShareProphets
- Watch Sage Group (SGE) by Alan Oscroft in The Motley Fool
- Avoid Fusion Antibodies (FAB) by Steve Moore in ShareProphets
- Watch 3i Group (III) by Jon Smith in The Motley Fool
- Buy Imperial Brands (IMB) by Goldman Sachs
- Buy Standard Chartered (STAN) by Simon Watkins in The Motley Fool
- Sector Perform CVS Group (CVSG) by RBC Capital
- Overweight Sage Group (SGE) by JP Morgan
- Overweight GB Group (GBG) by Barclays
- Buy Diploma (DPLM) by Deutsche Bank
- Buy CRH (CDI) (CRH) by Deutsche Bank
- Buy United Utilities Group (UU.) by Deutsche Bank
- Hold Crest Nicholson Holdings (CRST) by Jefferies
- Outperform HICL Infrastructure (HICL) by RBC Capital
- Buy Petershill Partners (PHLL) by Berenberg
- Buy Watches of Switzerland Group (WOSG) by Goldman Sachs
- Overweight Imperial Brands (IMB) by Barclays
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,359 open tips for GSK (GSK)
| Latest Bid : 1,302.00p | Latest Ask : 1,303.00p |
| High Today : 1,310.00p | Low Today : 1,299.50p |
| This Years High : 1,812.50p | This Years Low : 1,299.50p |
| Volume : 4,643,633 | MKT Cap : £54009.35M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2024-11-15 10:22:00 15/11/2024 | -1.14% |
| Hold | Jefferies | Premium Only | 2024-11-12 04:31:00 12/11/2024 | -5.38% |
| Equal Weight | Barclays | Premium Only | 2024-11-08 07:11:00 08/11/2024 | -6.73% |
| Neutral | Goldman Sachs | Premium Only | 2024-11-01 06:19:00 01/11/2024 | – |
| Buy | LBBW | Premium Only | 2024-10-31 10:20:00 31/10/2024 | -5.96% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,302.00p | Latest Ask : 1,303.00p |
| High Today : 1,310.00p | Low Today : 1,299.50p |
| This Years High : 1,812.50p | This Years Low : 1,299.50p |
| Volume : 4,643,633 | MKT Cap : £54009.35M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2024-11-15 10:22:00 15/11/2024 | -1.14% |
| Hold | Jefferies | Premium Only | 2024-11-12 04:31:00 12/11/2024 | -5.38% |
| Equal Weight | Barclays | Premium Only | 2024-11-08 07:11:00 08/11/2024 | -6.73% |
| Neutral | Goldman Sachs | Premium Only | 2024-11-01 06:19:00 01/11/2024 | – |
| Buy | LBBW | Premium Only | 2024-10-31 10:20:00 31/10/2024 | -5.96% |